Skip to search.
 TSX Down 0.39% TSX Ventures Up 0.28%

ZIOPHARM Oncology, Inc. (ZIOP)

-NasdaqCM
11.45 Up 0.34(3.02%) Mar 27, 4:00PM EDT
|After Hours : 11.48 Up 0.04 (0.31%) Mar 27, 7:37PM EDT
Add to Portfolio
Prev Close:11.11
Open:11.21
Bid:10.65 x 100
Ask:11.48 x 100
1y Target Est:16.67
Beta:0.49
Earnings Date:May 6 - May 11 (Est.)
Day's Range:11.15 - 11.93
52wk Range:2.31 - 14.40
Volume:5,781,590
Avg Vol (3m):4,653,610
Market Cap:1.19B
P/E (ttm):N/A
EPS (ttm):-0.31
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ZIOPUp 3.02%1.19B
IMGNUp 3.38%710.38M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):844.03
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.53
Quarterly EPS Est (Mar-15) :-0.13
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ZIOPHARM Oncology, Inc., a biotechnology company, focuses on acquiring, developing, and commercializing cancer therapies. The company is employing novel gene expression, and control and cells technologies to deliver cell-based therapies for the tr... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback